stockportfolio.pro
Chemed Corporation (CHE)
Healthcare · Medical Care Facilities · NYSE
Chemed Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.58B | $1.67B | $1.78B | $1.94B | $2.08B | $2.14B | $2.13B | $2.26B | $2.43B | $2.53B |
| Gross profit | $461.45M | $516.19M | $555.00M | $617.43M | $701.39M | $769.80M | $765.09M | $798.82M | $854.35M | $823.18M |
| Net income | $108.74M | $98.18M | $205.54M | $219.92M | $319.47M | $268.55M | $249.62M | $272.51M | $302.00M | $265.24M |
| Net margin | 6.9% | 5.9% | 11.5% | 11.3% | 15.4% | 12.6% | 11.7% | 12.0% | 12.4% | 10.5% |
Source: Chemed Corporation SEC filings (10-K). 18 years of history available in the interactive view.
What growth is priced into CHE stock?
At today's market cap of $5.75B, Chemed Corporation is priced for free-cash-flow growth of about 6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $325.48M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -5.4%/yr over the last five fiscal years and revenue 4%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 18 years of Chemed Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CHE in your portfolio →
Chemed Corporation financial history by metric
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Chemed Corporation — frequently asked questions
What is Chemed Corporation's revenue?
Chemed Corporation (CHE) reported revenue of $2.53B for fiscal year 2025, up 4.1% from the prior year, according to its SEC filings.
Is Chemed Corporation profitable?
Yes. CHE earned net income of $265.24M in fiscal 2025, a net margin of 10.5%.
What is CHE's P/E ratio?
Chemed Corporation trades at a price-to-earnings ratio of about 23.6 based on the latest data in our nightly-refreshed cache.
How fast is Chemed Corporation growing?
CHE's revenue grew at roughly 4.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Chemed Corporation have?
As of fiscal year 2025, CHE carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Chemed Corporation's gross margin?
CHE's gross margin was 32.5% in fiscal 2025 — gross profit of $823.18M on revenue of $2.53B.
What is Chemed Corporation's market cap?
Chemed Corporation (CHE) has a market capitalization of about $5.75B, based on the latest data in our nightly-refreshed cache.
When does Chemed Corporation's fiscal year end?
CHE's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CHE stock?
At today's market cap of $5.75B, Chemed Corporation is priced for free-cash-flow growth of about 6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $325.48M from the FY ending 2025-12-31). For comparison, free cash flow actually grew -5.4%/yr over the last five fiscal years and revenue 4%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Chemed Corporation's official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.